Navigation Links
Pomegranate juice may cut atherosclerosis risk in diabetics

An Israeli study has revealed that the risk of atherosclerosis in diabetics may be decreased by drinking pomegranate juice. This condition is characterized by// thickening and hardening of artery walls. 80% of the diabetics who die are affected by atherosclerosis.

This study, conducted by researchers at the Technion-Israel Institute of Technology revealed that there was a decrease in the risk of developing atherosclerosis in people who drank 180 ml (6 oz.) of pomegranate juice daily for a period of 90 days.

The uptake of oxidized LDL or “bad” cholesterol by immune cells called macrophages helps in the development of atherosclerosis. Pomegranate juice seems to prevent this uptake.

According to the lead researcher Professor Michael Aviram of the Technion Faculty of Medicine, though the sugars present in pomegranate juice were similar to those found in other fruit juices, these sugars did not aggravate diabetes.

"In most juices, sugars are present in free – and harmful – forms,” said Aviram. “In pomegranate juice, however, the sugars are attached to unique antioxidants, which actually make these sugars protective against atherosclerosis.”

Though this study was conducted on a small-scale, with only 20 participants, it is a part of a bigger proposal investigating the effects of pomegranates on cholesterol oxidation and cardiovascular diseases.

The antioxidant and anti-atherosclerotic benefits of licorice, olive oil, onions and pomegranates have already been worked upon by Aviram and also has published his findings. He was the first to prove inhibition of cholesterol oxidation and arteriosclerosis by consumption of red wine.

Decrease in risk of Alzheimer's disease, prostate cancer and heart disease by consuming pomegranate juice has already been proved in previous studies.

The current study is published in the August 2006 issue of Atherosclerosis.


Page: 1

Related medicine news :

1. Pomegranate Juice May Be The Next Best Thing For People With Heart Disease
2. Pomegranate juice to check fetal brain injury
3. Pomegranate juice delays prostate cancer
4. Pomegranate Juice Is Helpful In Arresting Osteoarthritis
5. Pomegranates Found To Slow Prostate Cancer Progression
6. Pomegranate Juice Consumption May Improve Myocardial Ischemia
7. Pomegranates In Snack-Sized Bars
8. Pomegranate Juice Remedy for Prostate Cancer
9. Pomegranate juice could kill cancer cells
10. Science Builds Behind Pomegranate Extracts for Health
11. Drink grape juice for health
Post Your Comments:

(Date:12/1/2015)... ... December 01, 2015 , ... ... of adjunctive imaging is the focus of numerous abstracts accepted for presentation here, ... 4, 2015. Nine abstracts highlight the use of Volpara Solutions’ quantitative breast ...
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, Calif. (December 1, ... organization has awarded Education and Developmental Therapies (EDT), an Applied Behavior Analysis (ABA) ... exceptional special needs providers that excel in synthesizing the areas of clinical quality, ...
(Date:12/1/2015)... ... 2015 , ... TCS Healthcare Technologies (TCS), a leading provider ... is pleased to announce that VIP Care Services, a Caprock Health Group affiliate ... Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY Complete ...
(Date:12/1/2015)... ... 01, 2015 , ... With FCPX Overlay: Grit , users can apply ... the possibilities are truly endless, all with a click of a mouse. Each user ... horizontal flip, depth of field and more, all within Final Cut Pro X. , ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... Contact Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes ... and support Cisco Unified Contact Center solutions targeted to the high-end enterprise contact ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015 Breg, Inc ., a premier ... that it has been awarded three contracts by Novation, ... Novation will have access to improved pricing for Breg,s ... soft goods dedicated to advancing orthopedic care.  ... U.S. population, rising prevalence of chronic conditions and the ...
(Date:12/1/2015)... Russia has always been a country of choice ... in Europe in 2015 were tested in phase ... has always been a country of choice for global multi-center ... Europe in 2015 were tested in phase II-III clinical ... has always been a country of choice for global multi-center phase III ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology: